Subscribe free to our newsletters via your
. Space Industry and Business News .




EPIDEMICS
Preemptive drug should be routine in AIDS fight: study
By Joshua MELVIN
Paris (AFP) Sept 9, 2015


Gay men at high risk of contracting HIV should have access to a daily dose of a drug used to treat the AIDS-causing virus, but as a preventive measure, researchers recommended Thursday.

The medicine, sold under the brand name Truvada, proved almost 90 percent effective at protecting men taking part in a British study, they wrote in The Lancet medical journal.

However, some worry that prescribing it as pre-exposure prophylaxis (PrEP) rather than treatment, would cause a jump in unsafe sex, and with it other sexually transmitted diseases, by removing the fear of contracting HIV.

There is also the prohibitive cost: a year's supply of Truvada, in a western European country, would cost around 7,000 euros ($7,700).

"National health services are under financial constraints, but they cannot afford to ignore the results," wrote the study authors, as they officially published the outcome of the study whose results have already been announced elsewhere.

The findings, they added: "strongly support the addition of PrEP to the current standard of prevention for men who have sex with men at risk of HIV infection."

In the 2012-2014 study, Truvada was given to 544 men who reported having had sex with other men in the previous three months without a condom.

Some were given the drug right away and others after a year -- the first group had an 86-percent lower risk than the second over the study period.

Researchers also observed no significantly higher risk of sexually transmitted diseases like syphilis among the protected group.

"Many gay men are at imminent risk of catching HIV and this is a way we can stop that," study co-author Sheena McCormack of University College London told AFP.

Michael Brady, medical director of the Terrence Higgins Trust, a British anti-HIV/AIDS charity, said the study was "an essential step towards ensuring access to PrEP for those who need it."

The drug has not been universally welcomed in the gay community, eliciting debate about promiscuity, erratic condom use and risks of worsening the stubborn HIV/AIDS epidemic which has killed 36 million people worldwide in the past three decades.

The drug is much less effective if not taken daily, some point out, which means forgetfulness could put your life at risk.


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle




Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News





EPIDEMICS
US Army orders lab safety review, freeze in anthrax scandal
Washington (AFP) Sept 3, 2015
The US military on Thursday ordered a production freeze and safety review at all defense department labs that handle biological agents and toxins including anthrax. It follows the discovery of evidence of anthrax contamination at the Dugway Proving Ground research center in the Utah desert, as well as shoddy record keeping at two other facilities, the Pentagon said. It is the latest twis ... read more


EPIDEMICS
Using ultrathin sheets to discover new class of wrapped shapes

Starshade identifies celestial objects at McMath-Pierce Solar Telescope

GSAT-6A's big antenna deployed by ISRO

US Needs to Upgrade Old Radars to Detect Russian Missiles - Carter

EPIDEMICS
Navy extends satellite support contract

MUOS-4 Responding Normally To Ground Control Post-Launch

US Military to Launch 'Smartphone' Communications Satellite on Monday

Russia, China discuss joint mobile satellite communications

EPIDEMICS
US Launches Atlas V Rocket With Navy Communications Satellite After Delay

FCube facility enters operations with fueling of Soyuz Fregat upper stage

SpaceX delays next launch after blast

GSLV Launches India's Latest Communication Satellite GSAT-6

EPIDEMICS
Galileo satellites fuelled and ready for launcher attachment

Denali, tallest peak in N.America, loses 10 feet

Latest Galileos closing in on launch

Russian Defense Ministry to use updated GLONASS GPS by 2016

EPIDEMICS
Confirmed MH370 wing part won't change search: Australia

China's Bohai to buy jet lessor Avolon in $7.6 bn deal

Tu-160 Heavy Strategic Bomber Undergoes Major Upgrade

USAF Next-Gen Long-Range Bomber Prototypes 'Mature' But Haven't Flown Yet

EPIDEMICS
Modified bacteria become a multicellular circuit

Superlattice design realizes elusive multiferroic properties

A little light interaction leaves quantum physicists beaming

SK Hynix to invest $38 billion over 10 years

EPIDEMICS
First global antineutrino emission map highlights Earth's energy budget

SMAP ends radar operations

Russia to Develop Earth Remote-Sensing Satellite System for Iran

Sentinel-1A watching Jakobshavn glacier in action

EPIDEMICS
Pollution dispersion in cities improved by trees

Mutation protects plants against harmful explosive, TNT

Poison in the Arctic and the human cost of 'clean' energy

India bars Greenpeace from receiving foreign funding




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.